Insider Transactions in Q4 2024 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
Gregory D Davis Head of Research & Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
505
-0.25%
|
$505
$1.94 P/Share
|
|
Nov 25
2024
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
10,642
-0.42%
|
$10,642
$1.94 P/Share
|
|
Nov 25
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-0.17%
|
$1,371
$1.94 P/Share
|
|
Nov 25
2024
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,508
-0.18%
|
$1,508
$1.94 P/Share
|
|
Nov 25
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-0.17%
|
$1,371
$1.94 P/Share
|
|
Nov 24
2024
|
Gregory D Davis Head of Research & Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
721
-0.36%
|
$721
$1.88 P/Share
|
|
Nov 24
2024
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
7,473
-0.3%
|
$7,473
$1.88 P/Share
|
|
Nov 24
2024
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,787
-0.22%
|
$1,787
$1.88 P/Share
|
|
Nov 24
2024
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,787
-0.21%
|
$1,787
$1.88 P/Share
|
|
Nov 24
2024
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,430
-0.17%
|
$1,430
$1.88 P/Share
|